Global Soft Tissue Sarcoma Targeted Drugs Supply, Demand and Key Producers, 2024-2030

March 2024 | 126 pages | ID: G62FF1C8821CEN
GlobalInfoResearch

Abstracts

The global Soft Tissue Sarcoma Targeted Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Soft Tissue Sarcoma Targeted Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Soft Tissue Sarcoma Targeted Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Soft Tissue Sarcoma Targeted Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Soft Tissue Sarcoma Targeted Drugs total market, 2019-2030, (USD Million)

Global Soft Tissue Sarcoma Targeted Drugs total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Soft Tissue Sarcoma Targeted Drugs total market, key domestic companies and share, (USD Million)

Global Soft Tissue Sarcoma Targeted Drugs revenue by player and market share 2019-2024, (USD Million)

Global Soft Tissue Sarcoma Targeted Drugs total market by Type, CAGR, 2019-2030, (USD Million)

Global Soft Tissue Sarcoma Targeted Drugs total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Soft Tissue Sarcoma Targeted Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Johnson & Johnson, GSK Plc, Teva Pharmaceuticals, Celgene, Bristol Myers Squibb, BeiGene and Shenzhen Chipscreen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Soft Tissue Sarcoma Targeted Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Soft Tissue Sarcoma Targeted Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Soft Tissue Sarcoma Targeted Drugs Market, Segmentation by Type

• Local Sarcoma
• Metastatic Sarcoma
• Other Sarcoma

Global Soft Tissue Sarcoma Targeted Drugs Market, Segmentation by Application

• Hospitals
• Oncology Centers
• Other

Companies Profiled:

• Roche
• Pfizer
• Johnson & Johnson
• GSK Plc
• Teva Pharmaceuticals
• Celgene
• Bristol Myers Squibb
• BeiGene
• Shenzhen Chipscreen
• Monopar Therapeutics
• Akeso Biopharma

Key Questions Answered

1. How big is the global Soft Tissue Sarcoma Targeted Drugs market?

2. What is the demand of the global Soft Tissue Sarcoma Targeted Drugs market?

3. What is the year over year growth of the global Soft Tissue Sarcoma Targeted Drugs market?

4. What is the total value of the global Soft Tissue Sarcoma Targeted Drugs market?

5. Who are the major players in the global Soft Tissue Sarcoma Targeted Drugs market?

Contents

1 SUPPLY SUMMARY

1.1 Soft Tissue Sarcoma Targeted Drugs Introduction
1.2 World Soft Tissue Sarcoma Targeted Drugs Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Soft Tissue Sarcoma Targeted Drugs Total Market by Region (by Headquarter Location)
  1.3.1 World Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2019-2030), (by Headquarter Location)
  1.3.2 United States Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
  1.3.3 China Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
  1.3.4 Europe Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
  1.3.5 Japan Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
  1.3.6 South Korea Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
  1.3.7 ASEAN Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
  1.3.8 India Soft Tissue Sarcoma Targeted Drugs Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Soft Tissue Sarcoma Targeted Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Soft Tissue Sarcoma Targeted Drugs Major Market Trends

2 DEMAND SUMMARY

2.1 World Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.2 World Soft Tissue Sarcoma Targeted Drugs Consumption Value by Region
  2.2.1 World Soft Tissue Sarcoma Targeted Drugs Consumption Value by Region (2019-2024)
  2.2.2 World Soft Tissue Sarcoma Targeted Drugs Consumption Value Forecast by Region (2025-2030)
2.3 United States Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.4 China Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.5 Europe Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.6 Japan Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.7 South Korea Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.8 ASEAN Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)
2.9 India Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030)

3 WORLD SOFT TISSUE SARCOMA TARGETED DRUGS COMPANIES COMPETITIVE ANALYSIS

3.1 World Soft Tissue Sarcoma Targeted Drugs Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Soft Tissue Sarcoma Targeted Drugs Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Soft Tissue Sarcoma Targeted Drugs in 2023
  3.2.3 Global Concentration Ratios (CR8) for Soft Tissue Sarcoma Targeted Drugs in 2023
3.3 Soft Tissue Sarcoma Targeted Drugs Company Evaluation Quadrant
3.4 Soft Tissue Sarcoma Targeted Drugs Market: Overall Company Footprint Analysis
  3.4.1 Soft Tissue Sarcoma Targeted Drugs Market: Region Footprint
  3.4.2 Soft Tissue Sarcoma Targeted Drugs Market: Company Product Type Footprint
  3.4.3 Soft Tissue Sarcoma Targeted Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Soft Tissue Sarcoma Targeted Drugs Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Soft Tissue Sarcoma Targeted Drugs Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
  4.1.2 United States VS China: Soft Tissue Sarcoma Targeted Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Soft Tissue Sarcoma Targeted Drugs Consumption Value Comparison
  4.2.1 United States VS China: Soft Tissue Sarcoma Targeted Drugs Consumption Value Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Soft Tissue Sarcoma Targeted Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Soft Tissue Sarcoma Targeted Drugs Companies and Market Share, 2019-2024
  4.3.1 United States Based Soft Tissue Sarcoma Targeted Drugs Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue, (2019-2024)
4.4 China Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue and Market Share, 2019-2024
  4.4.1 China Based Soft Tissue Sarcoma Targeted Drugs Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue, (2019-2024)
4.5 Rest of World Based Soft Tissue Sarcoma Targeted Drugs Companies and Market Share, 2019-2024
  4.5.1 Rest of World Based Soft Tissue Sarcoma Targeted Drugs Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue, (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Soft Tissue Sarcoma Targeted Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Local Sarcoma
  5.2.2 Metastatic Sarcoma
  5.2.3 Other Sarcoma
5.3 Market Segment by Type
  5.3.1 World Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2019-2024)
  5.3.2 World Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2025-2030)
  5.3.3 World Soft Tissue Sarcoma Targeted Drugs Market Size Market Share by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Soft Tissue Sarcoma Targeted Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Oncology Centers
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2019-2024)
  6.3.2 World Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2025-2030)
  6.3.3 World Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2019-2030)

7 COMPANY PROFILES

7.1 Roche
  7.1.1 Roche Details
  7.1.2 Roche Major Business
  7.1.3 Roche Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.1.4 Roche Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.1.5 Roche Recent Developments/Updates
  7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Pfizer
  7.2.1 Pfizer Details
  7.2.2 Pfizer Major Business
  7.2.3 Pfizer Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.2.4 Pfizer Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.2.5 Pfizer Recent Developments/Updates
  7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Details
  7.3.2 Johnson & Johnson Major Business
  7.3.3 Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.3.4 Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.3.5 Johnson & Johnson Recent Developments/Updates
  7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 GSK Plc
  7.4.1 GSK Plc Details
  7.4.2 GSK Plc Major Business
  7.4.3 GSK Plc Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.4.4 GSK Plc Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.4.5 GSK Plc Recent Developments/Updates
  7.4.6 GSK Plc Competitive Strengths & Weaknesses
7.5 Teva Pharmaceuticals
  7.5.1 Teva Pharmaceuticals Details
  7.5.2 Teva Pharmaceuticals Major Business
  7.5.3 Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.5.4 Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.5.5 Teva Pharmaceuticals Recent Developments/Updates
  7.5.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Celgene
  7.6.1 Celgene Details
  7.6.2 Celgene Major Business
  7.6.3 Celgene Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.6.4 Celgene Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.6.5 Celgene Recent Developments/Updates
  7.6.6 Celgene Competitive Strengths & Weaknesses
7.7 Bristol Myers Squibb
  7.7.1 Bristol Myers Squibb Details
  7.7.2 Bristol Myers Squibb Major Business
  7.7.3 Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.7.4 Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.7.5 Bristol Myers Squibb Recent Developments/Updates
  7.7.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.8 BeiGene
  7.8.1 BeiGene Details
  7.8.2 BeiGene Major Business
  7.8.3 BeiGene Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.8.4 BeiGene Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.8.5 BeiGene Recent Developments/Updates
  7.8.6 BeiGene Competitive Strengths & Weaknesses
7.9 Shenzhen Chipscreen
  7.9.1 Shenzhen Chipscreen Details
  7.9.2 Shenzhen Chipscreen Major Business
  7.9.3 Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.9.4 Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.9.5 Shenzhen Chipscreen Recent Developments/Updates
  7.9.6 Shenzhen Chipscreen Competitive Strengths & Weaknesses
7.10 Monopar Therapeutics
  7.10.1 Monopar Therapeutics Details
  7.10.2 Monopar Therapeutics Major Business
  7.10.3 Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.10.4 Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.10.5 Monopar Therapeutics Recent Developments/Updates
  7.10.6 Monopar Therapeutics Competitive Strengths & Weaknesses
7.11 Akeso Biopharma
  7.11.1 Akeso Biopharma Details
  7.11.2 Akeso Biopharma Major Business
  7.11.3 Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Product and Services
  7.11.4 Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.11.5 Akeso Biopharma Recent Developments/Updates
  7.11.6 Akeso Biopharma Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Soft Tissue Sarcoma Targeted Drugs Industry Chain
8.2 Soft Tissue Sarcoma Targeted Drugs Upstream Analysis
8.3 Soft Tissue Sarcoma Targeted Drugs Midstream Analysis
8.4 Soft Tissue Sarcoma Targeted Drugs Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Soft Tissue Sarcoma Targeted Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Soft Tissue Sarcoma Targeted Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Soft Tissue Sarcoma Targeted Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Soft Tissue Sarcoma Targeted Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Soft Tissue Sarcoma Targeted Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Soft Tissue Sarcoma Targeted Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Soft Tissue Sarcoma Targeted Drugs Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Soft Tissue Sarcoma Targeted Drugs Players in 2023
Table 12. World Soft Tissue Sarcoma Targeted Drugs Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Soft Tissue Sarcoma Targeted Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Soft Tissue Sarcoma Targeted Drugs Player
Table 15. Soft Tissue Sarcoma Targeted Drugs Market: Company Product Type Footprint
Table 16. Soft Tissue Sarcoma Targeted Drugs Market: Company Product Application Footprint
Table 17. Soft Tissue Sarcoma Targeted Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Soft Tissue Sarcoma Targeted Drugs Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Soft Tissue Sarcoma Targeted Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Soft Tissue Sarcoma Targeted Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue Market Share (2019-2024)
Table 23. China Based Soft Tissue Sarcoma Targeted Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue Market Share (2019-2024)
Table 26. Rest of World Based Soft Tissue Sarcoma Targeted Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Soft Tissue Sarcoma Targeted Drugs Revenue Market Share (2019-2024)
Table 29. World Soft Tissue Sarcoma Targeted Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2019-2024) & (USD Million)
Table 31. World Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2025-2030) & (USD Million)
Table 32. World Soft Tissue Sarcoma Targeted Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2019-2024) & (USD Million)
Table 34. World Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2025-2030) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 38. Roche Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Pfizer Basic Information, Area Served and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 44. Pfizer Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. Johnson & Johnson Basic Information, Area Served and Competitors
Table 48. Johnson & Johnson Major Business
Table 49. Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 50. Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Johnson & Johnson Recent Developments/Updates
Table 52. Johnson & Johnson Competitive Strengths & Weaknesses
Table 53. GSK Plc Basic Information, Area Served and Competitors
Table 54. GSK Plc Major Business
Table 55. GSK Plc Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 56. GSK Plc Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. GSK Plc Recent Developments/Updates
Table 58. GSK Plc Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Teva Pharmaceuticals Major Business
Table 61. Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 62. Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Teva Pharmaceuticals Recent Developments/Updates
Table 64. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Celgene Basic Information, Area Served and Competitors
Table 66. Celgene Major Business
Table 67. Celgene Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 68. Celgene Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Celgene Recent Developments/Updates
Table 70. Celgene Competitive Strengths & Weaknesses
Table 71. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 72. Bristol Myers Squibb Major Business
Table 73. Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 74. Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Bristol Myers Squibb Recent Developments/Updates
Table 76. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 77. BeiGene Basic Information, Area Served and Competitors
Table 78. BeiGene Major Business
Table 79. BeiGene Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 80. BeiGene Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. BeiGene Recent Developments/Updates
Table 82. BeiGene Competitive Strengths & Weaknesses
Table 83. Shenzhen Chipscreen Basic Information, Area Served and Competitors
Table 84. Shenzhen Chipscreen Major Business
Table 85. Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 86. Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Shenzhen Chipscreen Recent Developments/Updates
Table 88. Shenzhen Chipscreen Competitive Strengths & Weaknesses
Table 89. Monopar Therapeutics Basic Information, Area Served and Competitors
Table 90. Monopar Therapeutics Major Business
Table 91. Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 92. Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Monopar Therapeutics Recent Developments/Updates
Table 94. Akeso Biopharma Basic Information, Area Served and Competitors
Table 95. Akeso Biopharma Major Business
Table 96. Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Product and Services
Table 97. Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 98. Global Key Players of Soft Tissue Sarcoma Targeted Drugs Upstream (Raw Materials)
Table 99. Soft Tissue Sarcoma Targeted Drugs Typical Customers

LIST OF FIGURE

Figure 1. Soft Tissue Sarcoma Targeted Drugs Picture
Figure 2. World Soft Tissue Sarcoma Targeted Drugs Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Soft Tissue Sarcoma Targeted Drugs Total Market Size (2019-2030) & (USD Million)
Figure 4. World Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Soft Tissue Sarcoma Targeted Drugs Revenue (2019-2030) & (USD Million)
Figure 13. Soft Tissue Sarcoma Targeted Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 16. World Soft Tissue Sarcoma Targeted Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 18. China Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. India Soft Tissue Sarcoma Targeted Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Soft Tissue Sarcoma Targeted Drugs by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Soft Tissue Sarcoma Targeted Drugs Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Soft Tissue Sarcoma Targeted Drugs Markets in 2023
Figure 27. United States VS China: Soft Tissue Sarcoma Targeted Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Soft Tissue Sarcoma Targeted Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Soft Tissue Sarcoma Targeted Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Soft Tissue Sarcoma Targeted Drugs Market Size Market Share by Type in 2023
Figure 31. Local Sarcoma
Figure 32. Metastatic Sarcoma
Figure 33. Other Sarcoma
Figure 34. World Soft Tissue Sarcoma Targeted Drugs Market Size Market Share by Type (2019-2030)
Figure 35. World Soft Tissue Sarcoma Targeted Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Soft Tissue Sarcoma Targeted Drugs Market Size Market Share by Application in 2023
Figure 37. Hospitals
Figure 38. Oncology Centers
Figure 39. Other
Figure 40. Soft Tissue Sarcoma Targeted Drugs Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source